The role of law and governance reform in the global response to non-communicable diseases

Globalization and Health

Volumn 10, Issue 1, 2014, Pages

  Magnusson, Roger S ^a   Patterson, David ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b International Development Law Organization   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPACITY BUILDING; CIVIL SOCIETY; DISEASE; GOVERNANCE APPROACH; HUMAN IMMUNODEFICIENCY VIRUS; LEADERSHIP; LIFE EXPECTANCY; LONGEVITY; REFORM PROCESS; RISK FACTOR; HEALTH POLICY; POLICY IMPLEMENTATION; POLICY REFORM; SOCIAL IMPACT;

CAPACITY BUILDING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ECONOMIC ASPECT; GLOBAL LEADERSHIP; GOVERNANCE REFORM; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; LAW; LEADERSHIP; LIFE EXPECTANCY; LONGEVITY; LOWEST INCOME GROUP; MEDICAL INFORMATION SYSTEM; MEDICAL SOCIETY; MIDDLE INCOME GROUP; NON COMMUNICABLE DISEASE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION; ALCOHOL CONSUMPTION; BEHAVIOR CHANGE; COST EFFECTIVENESS ANALYSIS; DIET; DISEASE CONTROL; DISEASE SURVEILLANCE; GOVERNANCE FRAMEWORK; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; LEGAL ASPECT; LEGAL ASSISTANCE; LEGAL CAPACITY BUILDING; LEGISLATIVE FRAMEWORK; LIFESTYLE MODIFICATION; PACKAGING; PHYSICAL ACTIVITY; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; RIGHT TO HEALTH; RISK ASSESSMENT; RISK REDUCTION; SMOKING BAN; SMOKING CESSATION; SOCIAL ASPECTS AND RELATED PHENOMENA; SOCIAL IMPACT OF ILLNESS; STAFF TRAINING; TOBACCO; VACCINATION; CHRONIC DISEASE; DEVELOPING COUNTRY; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH; HEALTH BEHAVIOR; HEALTH CARE PLANNING; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT;

HARNESS;

CHRONIC DISEASE; DEVELOPING COUNTRIES; FINANCING, ORGANIZED; GLOBAL HEALTH; HEALTH BEHAVIOR; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LEADERSHIP; RISK FACTORS;

EID: 84903745015     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/1744-8603-10-44     Document Type: Review

References (182)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn S, AlMazroa M, Alvarado M, Anderson H, Anderson L, Andrews K, Atkinson C, Baddour L, Barker-Collo S, Bartels D, Bell M, Benjamin E, Bennett D, Bhalla K, Bikbov B, Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Burcello C, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012, 380:2095-2128. 10.1016/S0140-6736(12)61728-0, 23245604.
2. Hunter D, Reddy K. Noncommunicable diseases. N Engl J Med 2013, 369:1336-1343. 10.1056/NEJMra1109345, 24088093.
3. World Health Organization Noncommunicable Diseases: Country Profiles 2011 2011, Geneva: World Health Organization, World Health Organization.
4. World Health Organization Global Status Report on Noncommunicable Diseases 2011, Geneva: World Health Organization, World Health Organization.
5. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, . for The Lancet NCD Action Group and the NCD Alliance Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447. 10.1016/S0140-6736(11)60393-0, 21474174, for The Lancet NCD Action Group and the NCD Alliance.
6. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, AlMazroa MA, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260. 10.1016/S0140-6736(12)61766-8, 23245609.
7. World Economic Forum and World Health Organization From Burden to " Best Buys": Reducing the Economic Impact of non-Communicable Diseases in low- and Middle-Income Countries 2011, Geneva: World Economic Forum and World Health Organization, World Economic Forum and World Health Organization.
8. Sivaramakrishnan K, Parker R. The united nations high level meeting on the prevention and control of noncommunicable diseases: a missed opportunity?. Am J Public Health 2012, 102:2010-2012. 10.2105/AJPH.2012.300768, 22994178.
9. The World Bank The Growing Danger of non-Communicable Diseases: Acting now to Reverse Course. Conference Edition 2011, Washington DC: World Bank, The World Bank.
10. The World Bank Towards a Healthy and Harmonious Life in China 2011, Washington DC: World Bank, The World Bank.
11. World Health Organization Draft Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. A66/9, Appendix 3 (Endorsed WHA May 2013) 2013, Geneva: World Health Organization, World Health Organization.
12. Chisholm D, Edejer TT-T, Baltussen R, Evans DB, Ginsberg G, Lauer JA, Lim S, Ortegon M, Salomon J, Stanciole A. What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia?. BMJ 2012, 344:e586. 10.1136/bmj.e586, 22389336.
13. Jamison DT, Frenk J, Ghosh G, Goldie SJ, Guo Y, Gupta S, Horton R, Kruk ME, Mahmoud A, Mohohlo LK, Ncube M, Summers LH, Pablos-Mendez A, Reddy KS, Saxenian H, Soucat A, Ulltveit-Moe KH, Ulltveit-Moe KH, Yamey G, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, Bustreo F, Evans D, Feachem RGA. Global health 2035: a world converging within a generation. Lancet 2013, 382:1898-1955. at 1926-1927, 10.1016/S0140-6736(13)62105-4, 24309475.
14. World Health Organization WHO Framework Convention on Tobacco Control. WHA56.1 (entered into force 27 February 2005) 2003, Geneva: World Health Organization, World Health Organization.
15. World Health Organization Global Strategy to Reduce the Harmful Use of Alcohol WHA63/13 - Annex 2 (Endorsed WHA May 2010) 2010, Geneva: World Health Organization, World Health Organization.
16. World Health Organization WHO Global Strategy on Diet, Physical Activity and Health. WHA57.17. (Endorsed WHA May 2004) 2004, Geneva: World Health Organization, World Health Organization.
17. World Health Organization Set of Recommendations on the Marketing of Foods and non-Alcoholic Beverages to Children (WHA63.14, Endorsed WHA May 2010) 2010, Geneva: World Health Organization, World Health Organization.
18. World Health Organization A Framework for Implementing the set of Recommendations on the Marketing of Foods and non-Alcoholic Beverages to Children 2012, Geneva, World Health Organization.
19. World Health Organization 65th World Health Assembly closes with new global health measures. [http://www.who.int/mediacentre/news/releases/2012/wha65_closes_20120526/en/index.html], World Health Organization.
20. International Diabetes Federation Global diabetes plan 2011-2021. [http://www.idf.org/global-diabetes-plan-2011-2021], International Diabetes Federation.
21. Bonita R, Hospedales J, de Courten M, Capewell S, Beaglehole R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, Suh I, Thankappan KR, McKee M, . Lancet NCDAG, Lancet NCDAG Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet 2013, 381:575-584. 10.1016/S0140-6736(12)61993-X, 23410607, Lancet NCDAG, Lancet NCDAG.
22. World Health Organization Constitution of the World Health Organization (Preamble) 1948, Geneva: World Health Organization, World Health Organization.
23. UN General Assembly International Covenant on Economic, Social and Cultural Rights 1966, 993:3. United Nations, Treaty Series, Article 12, UN General Assembly.
24. Organization of African Unity (OAU) African Charter on Human and Peoples' Rights ("Banjul Charter") June 1981,?CAB/LEG/67/3 rev. 5, 21 I.L.M. 58 (1982), Article 16, Organization of African Unity (OAU).
25. Council of Europe European Social Charter (Revised) 3 May 1996,?ETS 163, Article 11, Council of Europe.
26. Organization of American States (OAS) Additional Protocol to the American Convention on Human Rights in the Area of Economic, Social and Cultural Rights ("Protocol of San Salvador") 16 November 1999,?A-52, articles 10-11, Organization of American States (OAS).
27. Constituição Federal de 1988 [Federal Constitution of 1988] Brazil.
28. Lamptey P, Dirks R. Building on the AIDS response to tackle noncommunicable disease. Global Heart 2012, 7:67-71.
29. NCD Alliance Noncommunicable diseases: a priority for women's health and development. NCD Alliance; 2011. [http://ncdalliance.org/womenandncds], NCD Alliance.
30. United Nations Development Program Discussion paper: addressing the social determinants of noncommunicable diseases 2013, New York, United Nations Development Program.
31. Brawley O. Avoiding cancer deaths globally. CA Cancer J Clin 2011, 61:67-68. 10.3322/caac.20108, 21296854.
32. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14. 10.1016/j.diabres.2009.10.007, 19896746.
33. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007, 370:2044-2053. 10.1016/S0140-6736(07)61698-5, 18063027.
34. World Health Organization Scaling up Action Against Noncommunicable Diseases: how Much Will it Cost? 2011, Geneva: World Health Organization, World Health Organization.
35. Cecchini M, Sassi F, Lauer J, Lee Y, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 2010, 376:1775-1784. 10.1016/S0140-6736(10)61514-0, 21074255.
36. McGrady B. Trade and Public Health: The WTO, Tobacco, Alcohol, and Diet 2011, Cambridge: Cambridge University Press.
37. Mitchell A, Voon T. Implications of the World Trade Organization in combating non-communicable diseases. Public Health 2011, 125:832-839. 10.1016/j.puhe.2011.09.003, 22030320.
38. Voon T. Flexibilities in WTO law to support tobacco control regulation. Am J Law Med 2013, 39:199-217.
39. World Health Organization Discussion paper. Intersectoral action on health: a path for policy-makers to implement effective and sustainable intersectoral action on health. First global ministerial conference on healthy lifestyles and noncommunicable disease control, Moscow, 28-29 April, 2011. [http://www.who.int/nmh/publications/ncds_policy_makers_to_implement_intersectoral_action.pdf], World Health Organization.
40. World Health Organization Discussion paper. Effective approaches for strengthening multisectoral action for NCDs, 19 March 2012. [http://www.who.int/nmh/events/2012/consultation_march_2012/en/index.html], World Health Organization.
41. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, . Lincoln P for the Lancet NCD Action Group UN high-level meeting on non-communicable diseases: addressing four questions. Lancet 2011, 378:449-455. 10.1016/S0140-6736(11)60879-9, 21665266, Lincoln P for the Lancet NCD Action Group.
42. World Health Organization Prevention and control of noncommunicable diseases: options and a timeline for strengthening and facilitating multisectoral action for the prevention and control of noncommunicable diseases through partnership: report by the Secretariat. Sixty-fifth World Health Assembly. 15 May 2012, A65/7. World Health Organization.
43. World Health Organization The World Health Report 2003: Shaping the Future 2003, Geneva: World Health Organization, World Health Organization.
44. Bayer R. Private Acts, Social Consequences 1989, New York: Macmillan.
45. HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services (USA), updated 12 February 2013. [http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf], HHS Panel on Antiretroviral Guidelines for Adults and Adolescents.
46. Smith L, Ramakrishnan U, Ndiaye A, Haddad L, Martorell R. The importance of women's status for child nutrition in developing countries; International Food Policy Research Institute, Research report 131, 2003. [http://www.ifpri.org/publication/importance-womens-status-child-nutrition-developing-countries].
47. Choudhury K, Hanifi M, Rasheed S, Bhuiya A. Gender inequality and severe malnutrition among children in a remote rural area of Bangladesh. J Health Popul Nutr 2000, 18:123-130.
48. Darnton-Hill I, Webb P, Harvey PWJ, Hunt JM, Dalmiya N, Chopra M, Ball MJ, Bloem MW, de Benoist B. Micronutrient deficiencies and gender: social and economic costs. Am J Clin Nutr 2005, 81:1198S-1205S.
49. Pell JP, Pell ACH, Dunn F, Oldroyd K, MacIntyre P, O'Rourke B, Borland W, Haw S, Cobbe S, Newby DE, Fischbacher C, McConnachie A, Pringle S, Murdoch D. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008, 359:482-491. 10.1056/NEJMsa0706740, 18669427.
50. Sims M, Maxwell R, Bauld L, Gilmore A. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 2010, 340:c2161. 10.1136/bmj.c2161, 2882555, 20530563.
51. Ferrante D, Linetzky B, Virgolini M, Schoj V, Apelberg B. Reduction in hospital admissions for acute coronary syndrome after the successful implementation of 100% smoke-free legislation in Argentina: a comparison with partial smoking restrictions. Tob Control 2012, 21:402-406. 10.1136/tc.2010.042325, 21602536.
52. Barnoya J, Glantz S. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005, 111:2684-2698. 10.1161/CIRCULATIONAHA.104.492215, 15911719.
53. Been JV, Nurmatov UB, Cox B, Nawrot TS, Schayck CP, Sheikh A. Effect of smoke-free legislation on perinatal and child health: a systematic review and analysis. Lancet 2014, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60082-9/fulltext.
54. World Health Organization The World Health Report: Health Systems Financing: The Path to Universal Coverage 2010, Geneva: World Health Organization, World Health Organization.
55. United Nations Economic and Social Council General Comment No. 14. The Right to the Highest Attainable Standard of Health 2000, Geneva: United Nations Economic and Social Council, United Nations Economic and Social Council.
56. Backman G, Frisancho A, Tarco D, Motlagh M, Farcasanu D, Vladescu C, Hunt P, Khosla R, Jaramillo-Strouss C, Fikre BM, Rumble C, Pevalin D, Páez DA, Pineda MA. Health systems and the right to health: an assessment of 194 countries. Lancet 2008, 372:2047-2085. 10.1016/S0140-6736(08)61781-X, 19097280.
57. World Health Organization Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low Resource Settings 2010, Geneva: World Health Organization, World Health Organization.
58. Lim S, Gaziano T, Gakidou E, Reddy K, Farzadfar F, Lozano R, Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007, 370:2054-2062. 10.1016/S0140-6736(07)61699-7, 18063025.
59. Yusuf S, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Islam S, Yusoff K, Zatonski W, Rosengren A, Teo KK, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011, 378:1231-1243. 10.1016/S0140-6736(11)61215-4, 21872920.
60. Niëns L, Cameron A, Van de Poel E, Ewen M, Brouwer W, Laing R. Quantifying the impoverishing effect of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med 2010, 7:e1000333. 10.1371/journal.pmed.1000333, 2930876, 20824175.
61. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009, 373:240-249. 10.1016/S0140-6736(08)61762-6, 19042012.
62. Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, Leowski J, Ewen M. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007, 85:279-288. 10.2471/BLT.06.033647, 2636320, 17546309.
63. World Health Organization The World Health Report, 2008: Primary Health Care (Now, More Than Ever) 2008, Geneva: World Health Organization, World Health Organization.
64. Samb B, Patel K, Adshead F, McKee M, Evans T, Alwan A, Etienne C, Desai N, Nishtar S, Mendis S, Bekedam H, Wright A, Hsu J, Martiniuk A, Celletti F. Chronic diseases: chronic diseases and development 4 prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010, 376:1785-1797. 10.1016/S0140-6736(10)61353-0, 21074253.
65. World Health Organization Everybody's Business: Strengthening Health Systems to Improve Health Outcomes: WHO's Framework for Action 2007, Geneva, [http://www.who.int/healthsystems/strategy/en/], World Health Organization.
66. Kutzin J. Health financing for universal coverage and health system performance: concepts and implications for policy. Bull World Health Organ 2013, 91:62-611.
67. Kinney E, Clark B. Provisions for health and health care in the constitutions of the countries of the world. Cornell Int Law J 2004, 37:285-355.
68. Sentencia T-760/08 Acciones de Tutela Instauradas por Luz Mary Osorio Palacio Contra Colpatria EPS Colombia: Corte Constitucional de Colombia, 31 julio 2008 (expediente T-1281247), Sentencia T-760/08.
69. See Azanca Alheli Meza García Peru: Tribunal Constitucional de Peru, 20 abril 2004 (expediente 2945-2003-AA/TC).
70. Sentencia 196 Cruz del Valle Bermúdez y otros v. MSAS s/amparao Venezuela: Tribunal Supreme de Venezuela, 15 mayo 1999 (expediente 15.789), Sentencia 196.
71. Puhl R, Heuer C. The stigma of obesity: a review and update. Obesity 2009, 17:941-964. 10.1038/oby.2008.636, 19165161.
72. Kalra B, Kalra S, Kumar A. Social stigma and discrimination: a care crisis for young women with diabetes in India. Diabetes Voice 2009, 54(Special Issue):37-39.
73. World Health Organization Medium-Term Strategic Plan 2008-2013. [http://apps.who.int/gb/ebwha/pdf_files/MTSP-08-13-PPB-10-11/mtsp-3en.pdf], World Health Organization.
74. Abegunde D. Essential medicines for non-communicable diseases (NCDs). Background paper. http://www.who.int/medicines/areas/policy/access_noncommunicable/EssentialMedicinesforNCDs.pdf.
75. Agreement on Trade-Related Aspects of Intellectual Property Rights: Marrakesh Agreement Establishing the World Trade Organization Annex 1C, The legal texts: the results of the Uruguay round of multilateral trade negotiations 321 (1999), 1869 UNTS 299. [http://www.wto.org/english/docs_e/legal_e/legal_e.htm#TRIPs], Agreement on Trade-Related Aspects of Intellectual Property Rights: Marrakesh Agreement Establishing the World Trade Organization.
76. Musungu S, Oh C. The use of flexibilities in TRIPS by developing countries: can they promote access to medicines? Geneva: World Health Organization; 2005. [http://www.who.int/intellectualproperty/studies/TRIPSFLEXI.pdf].
77. Abbott F, van Puymbroeck R. Compulsory licensing for public health: a guide and model documents for implementation of the DOHA Declaration Paragraph 6 Decision. Washington DC: The World Bank; 2005. [http://documents.worldbank.org/curated/en/2005/07/6258659/compulsory-licensing-public-health-guide-model-documents-implementation-doha-declaration-paragraph-6-decision].
78. Van Puymbroeck R. Basic survival needs and access to medicines - coming to grips with TRIPS: conversion + calculation. J Law Med Ethics 2010, 38:520-549. 10.1111/j.1748-720X.2010.00510.x, 20880239.
79. Nicol D, Owoeye O. Using TRIPS flexibilities to facilitate access to medicines. Bull World Health Organ 2013, 91:533-539. 10.2471/BLT.12.115865, 3699798, 23825881.
80. United Nations General Assembly Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. A/66/L.1 (New York, 16 September 2011). United Nations General Assembly.
81. Bollyky T. Access to drugs for treatment of noncommunicable diseases. PLoS Med 2013, 10(7):e10011485.
82. Gabble R, Kohler JC. 'To patent or not to patent?' the case of Novartis' cancer drug Glivec in India. Glob Health 2014, 10:3. [http://www.globalizationandhealth.com/content/10/1/3].
83. Glassman A, Duran D, Sumner A. Global health and the new bottom billion: what do shifts in global poverty and disease burden mean for donor agencies?. Global Policy 2013, 4:1.
84. World Health Organization Ensuring Balance in National Policies on Controlled Substances: Guidance for Availability and Accessibility of Controlled Medicines 2011, Geneva: World Health Organization, World Health Organization.
85. Lohman D, Schleifer R, Amon J. Access to pain treatment as a human right. BMC Med 2010, 8:8. 10.1186/1741-7015-8-8, 2823656, 20089155.
86. United Nations Pain initiative at the United Nations. [http://www.pain-initiative-un.org/pain-initiative4/], United Nations.
87. International Association for the Study of Pain Declaration of Montréal, adopted 3 September 2010. [http://www.iasp-pain.org/Advocacy/Content.aspx?ItemNumber=1821], International Association for the Study of Pain.
88. Liberman J. Implications of international law for the treatment of cancer: the single convention on narcotic drugs and the TRIPS agreement. Public Health 2011, 125:840-846. 10.1016/j.puhe.2011.09.032, 22054908.
89. World Health Organization WHO Report on the Global Tobacco Epidemic 2013, Geneva, World Health Organization.
90. Garrett L. So, What Was Accomplished? The UN and NCDs. [http://lauriegarrett.com/blog/2011/9/22/so-what-was-accomplished-the-un-and-ncds].
91. Rabkin M, El-Sadr W. Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Health 2011, 6:247-256. 10.1080/17441692.2011.552068, 21390970.
92. Stuckler D, Nestle M. Big food, food systems, and global health. PLoS Med 2012, 9(6):e1001242. 10.1371/journal.pmed.1001242, 3378592, 22723746.
93. Moodie R, Swinburn B, Richardson J, Somaini B. Childhood obesity - a sign of commercial success, but a market failure. Int J Pediatr Obes 2006, 1:133-138. 10.1080/17477160600845044, 17899630.
94. Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med 2012, 9(6):e1001245. 3393664, 22802730.
95. Labonté R, Mohindra K, Lenchucha R. Framing international trade and chronic disease. Global Health 2011, 7:21. 10.1186/1744-8603-7-21, 3158109, 21726434.
96. Hawkes C, Chopra M, Friel S. Globalization, Trade and the Nutrition Transition. Globalization and Health: Pathways, Evidence and Policy 2009, 235-262. New York: Routledge, Labonté R, Schrecker T, Packer C, Runnels V.
97. Hastings G. Why corporate power is a public health priority. BMJ 2012, 34:e5124.
98. Food Industry Asia The contribution of food & beverage companies to health and nutrition in Asia. Summary of initiatives - 2012. [https://foodindustry.asia/documentdownload.axd?documentresourceid=379], Food Industry Asia.
99. Kusnandar & Co It's not necessary for Indonesia to ratify the FCTC. [blogpost]. 9 January 2014 [http://kusnandarlaw.blogspot.com.au/2014/01/its-not-necessary-yet-for-indonesia-to.html], Kusnandar & Co.
100. Friel S, Gleeson D, Thow A-M, Labonte R, Stuckler D, Kay A, Snowdon W. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement. Global Health 2013, 9:46. 10.1186/1744-8603-9-46, 4016302, 24131595.
101. Thow AM, McGrady B. Protecting policy space for public health nutrition in an era of international investment agreements. Bull World Health Organ 2014, 92:139-145. 10.2471/BLT.13.120543, 3949531, 24623907.
102. Philip Morris Brand Sàrl (Switzerland), Philip Morris Products S.A. (Switzerland) and AbalHermanos S.A. (Uruguay) v. Oriental Republic of Uruguay (ICSID Case No. ARB/10/7) International Centre for Settlement of Investor Disputes. [https://icsid.worldbank.org/ICSID/FrontServlet?requestType=GenCaseDtlsRH&actionVal=ListPending], Philip Morris Brand Sàrl (Switzerland), Philip Morris Products S.A. (Switzerland) and AbalHermanos S.A. (Uruguay) v. Oriental Republic of Uruguay (ICSID Case No. ARB/10/7).
103. Voon T, Mitchell A, Liberman J, Ayres G. Public Health and Plain Packaging of Cigarettes 2012, Cheltenham: Edward Elgar Publishing.
104. Daube M, Stafford J, Bond L. No need for Nanny. Tob Control 2008, 17:426-427. 10.1136/tc.2008.027763, 19029365.
105. Jochelson K. Nanny or steward? The role of government in public health. Public Health 2006, 120:1149-1155. 10.1016/j.puhe.2006.10.009, 17067645.
106. Brownell K, Kersh R, Ludwig D, Post R, Puhl R, Schwarts M, Willett W. Personal responsibility and obesity: a constructive approach to a controversial issue. Health Aff 2010, 29:379-387.
107. Hitchens C. I fought the law. Vanity Fair 2004, 74-79.
108. Hall M. The scope and limits of public health. Perspect Biol Med 2003, 46(3):S199-S209. 10.1353/pbm.2003.0054, 14563083.
109. Calman K. Beyond the 'Nanny State': stewardship and public health. Public Health 2009, 123:e6-e10.
110. Wikler D. Personal and social responsibility for health. Ethics Int Aff 2002, 16:47-55. 10.1111/j.1747-7093.2002.tb00396.x, 15709278.
111. Magnusson R. Bloomberg, Hitchins, and the Libertarian Critique. Hastings Cent Rep 2014, 44(1):3-4.
112. Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet 2012, 379:1269-1271. 10.1016/S0140-6736(11)60615-6, 3260384, 21963004.
113. Zhu C, Young-soo S, Beaglehole R. Tobacco control in China: small steps towards a giant leap. Lancet 2012, 379:779-780. 10.1016/S0140-6736(11)61933-8, 22386013.
114. World Health Organization Regional Office for South-East Asia. Noncommunicable Diseases in the South-East Asia Region, 2011 - Situation and Response 2011, Geneva: World Health Organization, World Health Organization.
115. Djono A. Indonesia 'blowing smoke' over tobacco control. Jakarta Globe. 8 November 2013. [http://www.thejakartaglobe.com/news/indonesia-blowing-smoke-over-tobacco-control/].
116. World Health Organization MPOWER: a policy package to reverse the tobacco epidemic. [http://www.who.int/tobacco/mpower/en/], World Health Organization.
117. Méndez D, Alshanqeety O, Warner K. The potential impact of smoking control policies on future global smoking trends. Tob Control 2012, 22:46-51.
118. Beaglehole R, Bonita R, Horton R, Ezzati M, Bhala N, Amuyunzu-Nyamongo M, Mwatsama M, Reddy KS. Measuring progress on NCDs: one goal and five targets. Lancet 2012, 380:1283-1285. 10.1016/S0140-6736(12)61692-4, 23063272.
119. Capewell S, O'Flaherty M. Rapid mortality falls after risk-factor changes in populations. Lancet 2011, 378:752-753. 10.1016/S0140-6736(10)62302-1, 21414659.
120. Institute of Medicine Country-Level Decision-Making for Control of Chronic Diseases. Workshop Summary 2012, Washington DC: The National Academies Press, Institute of Medicine.
121. Kelly B, Pérez Koehlmoos T, Nugent R. Exploring country-level decision making for the control of chronic diseases. Global Heart 2012, 7(1):7-12.
122. Hawkes C, Jewell J, Allen K. A food policy package for healthy diets and the prevention of obesity and diet-related non-communicable diseases: the NOURISHING framework. Obes Rev 2013, 14(Suppl 2):159-168.
123. Gostin L. Bloomberg's Health Legacy: Urban Innovator or Meddling Nanny. Hastings Cent Rep 2013, 43(5):19-25.
124. Lorillard Tobacco Co. v Reilly 121 S. Ct. 2404 (2001) (U.S. Supreme Court); 44 Liquormart, Inv. v Rhode Island 517 U.S. 484 (1996) (U.S. Supreme Court) Lorillard Tobacco Co. v Reilly.
125. R.J. Reynolds Tobacco Co. V Food & Drug Administration U.S. Court of Appeals for the District of Columbia 24 August 2012. No. 11-5332, R.J. Reynolds Tobacco Co. V Food & Drug Administration.
126. Gostin L. Public Health Law: Power, Duty, Restraint 2008, Berkeley: University of California Press.
127. Berman M. Commercial speech law and tobacco marketing: a comparative discussion of the United States and Canada. Am J Law Med 2013, 39:218-236.
128. Cabrera O, Madrazo A. Human rights as a tool for tobacco control in Latin America. Salud Publica Mex 2010, 52(suppl 2):S288-S297.
129. Murli S. Deora v. Union of India, 8 SSC 765 Supreme Court of India 2001, Murli S. Deora v. Union of India, 8 SSC 765.
130. Cigarettes and Other Tobacco Products Act 2003 Cigarettes and Other Tobacco Products Act 2003. (India) [http://www.tobaccocontrollaws.org/legislation/country/India], Cigarettes and Other Tobacco Products Act 2003.
131. Campaign for Tobacco-Free Kids International Legal Consortium. Litigation Project. [http://www.tobaccocontrollaws.org/litigation], Campaign for Tobacco-Free Kids.
132. Australian Associated Press Mild, light cigarette descriptions axed. The Sydney Morning Herald 7 November 2005, Australian Associated Press.
133. Rani M, Nusrat S, Hawken L. A qualitative study of governance of evolving response to non-communicable diseases in low- and middle-income countries: current status, risks and options. BMC Public Health 2012, 12:877. 10.1186/1471-2458-12-877, 3487912, 23067232.
134. Borland R, Winstanley M, Reading D. Legislation to institutionalize resources for tobacco control: the 1987 Victorian Tobacco Act. Addiction 2009, 104:1623-1629. 10.1111/j.1360-0443.2009.02701.x, 21265905.
135. Brownell K, Farley T, Willett W, Popkin B, Chaloupka F, Thompson J, Ludwig D. The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med 2009, 361:1599-1605. 10.1056/NEJMhpr0905723, 3140416, 19759377.
136. Claro R, Levy R, Popkin B, Monteiro C. Sugar-sweetened beverage taxes in Brazil. Am J Pub Health 2012, 102:178-183.
137. Briggs A, Mytton O, Kehlbacher A, Tiffin R, Rayner M, Scarborough P. Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in the UK: econometric and comparative risk assessment modelling study. BMJ 2013, 347:f6189. 10.1136/bmj.f6189, 3814405, 24179043.
138. ACUERDO por el que se crea el Consejo Nacionalpara la Prevención y Control de las Enfermeda des Crónicas No Transmisibles. 11 February 2010. [http://dof.gob.mx/nota_detalle.php?codigo=5131456&fecha=11/02/2010].
139. Patient Protection and Affordable care act (P.L. 111-148), Title IV (§4001); Executive Order 13544. Establishing the National Prevention, Health Promotion, and Public Health Council. 10 June 2010. [http://www.whitehouse.gov/the-press-office/executive-order-establishing-national-prevention-health-promotion-and-public-health].
140. National Prevention Council. [http://www.surgeongeneral.gov/initiatives/prevention/about/index.html].
141. National Prevention Council National Prevention Council Action Plan: Implementing the National Prevention Strategy. [http://www.surgeongeneral.gov/initiatives/prevention/about/actionplan.html], National Prevention Council.
142. UNAIDS UN support to country level responses to HIV/AIDS: an in-depth assessment of UN Theme Groups on HIV/AIDS. [http://www.undg.org/content/programming_reference_guide_%28undaf%29/thematic_policies_and_guidelines], UNAIDS.
143. UNAIDS Resource Guide for UN Theme Groups on HIV/AIDS 2005, Geneva: UNAIDS, UNAIDS.
144. Editorial Alcohol misuse needs a global response. Lancet 2007, 373:433. Editorial.
145. Editorial Urgently needed: a framework convention on obesity control. Lancet 2011, 378:741. 10.1016/S0140-6736(11)61356-1, 21872731, Editorial.
146. Gostin LO, Friedman EA, Buse K, Waris A, Mulumba M, Joel M, Dare L, Dhai A, Sridhar D. Towards a framework convention on global health. Bull World Health Organ 2013, 91:790-793. 10.2471/BLT.12.114447, 3791648, 24115803.
147. United Nations General Assembly The future we want. A/RES/66/288. [http://www.uncsd2012.org/thefuturewewant.html], United Nations General Assembly.
148. United Nations A new global partnership: eradicate poverty and transform economies through sustainable development. The report of the high-level panel of eminent persons on the post-2015 development agenda. New York; 2013, United Nations.
149. World Health Assembly: Follow-up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases (WHA66.10, 27 May 2013) (annexing the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020).
150. United Nations Economic and Social Council United Nations Interagency Task Force on the Prevention and Control of Non-communicable Diseases, E/2013/L.23. 2013, Geneva: United Nations, United Nations Economic and Social Council.
151. World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, WHA66.10. 2013, Geneva: World Health Organization, World Health Organization.
152. World Health Organization UN Interagency Task Force on the Prevention and Control of NCDs. [website] [http://www.who.int/nmh/events/ncd_task_force/en/], World Health Organization.
153. World Health Organization Draft terms of reference for the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases. WHO Discussion Paper (2 September 2013), World Health Organization.
154. World Health Organization Terms of reference for the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases, including a division of tasks and responsibilities for UN organizations and other intergovernmental organizations. WHO Discussion Paper (4 October 2013), World Health Organization.
155. World Health Organization Draft terms of reference for a global coordination mechanism for the prevention and control of noncommunicable diseases. WHO Discussion Paper (23 July 2013), World Health Organization.
156. World Health Organization Global coordination mechanism for NCDs. [website] [http://www.who.int/nmh/events/ncd_coordination_mechanism/en/], World Health Organization.
157. The global fund to fight AIDS, tuberculosis and malaria. [http://www.theglobalfund.org/en/].
158. Institute for Health Metrics and Evaluation Financing Global Health 2012: The end of the Golden age? 2012, Seattle: Institute for Health Metrics and Evaluation, Institute for Health Metrics and Evaluation.
159. United Nations General Assembly Note by the Secretary-General transmitting the report of the Director-General of the World Health Organization on options for strengthening and facilitating multisectoral action for the prevention and control of non-communicable diseases through effective partnership. A/67/373 (17 September 2012), United Nations General Assembly.
160. Magnusson R. Rethinking global health challenges: towards a 'global compact' for reducing the burden of chronic disease. Public Health 2009, 123:265-274. 10.1016/j.puhe.2008.12.023, 19278695.
161. Magnusson R. Non-communicable diseases and global health governance: enhancing global processes to improve health development. Glob Health 2007, 3:2. [http://www.globalizationandhealth.com/content/3/1/2].
162. World Health Organization Comprehensive Global Monitoring Framework, Including 25 Indicators, and a set of Nine Voluntary Global Targets for the Prevention and Control of Noncommunicable Diseases 2013, Geneva: World Health Organization, World Health Organization.
163. World Health Organization Set of action plan indicators for the WHO Global NCD Action Plan 2013-2020. [http://www.who.int/nmh/events/action_plan_indicators/en/index.html], World Health Organization.
164. World Health Organization Country profile of capacity and responses to noncommunicable diseases (NCDs), 2013. [http://www.who.int/chp/ncd_capacity/CCS_2013_Questionnaire.pdf], World Health Organization.
165. Swinburn B, Sacks G, Vandevijvere S, Kumanyika S, Lobstein T, Neal B, Barquera S, Friel S, Hawkes C, Kelly B, L'Abbe M, Lee A, Ma J, Macmullan J, Mohan S, Monteiro C, Rayner M, Sanders D, Snowdon W, Walker C. INFORMAS: (International network for food and obesity/non-communicable diseases research, monitoring and action support): overview and key principles. Obes Rev 2013, 14(Suppl 1):1-12.
166. INFORMAS Benchmarking food environments. [website] [http://www.fmhs.auckland.ac.nz/soph/globalhealth/informas/], INFORMAS.
167. UNAIDS Global AIDS response progress reporting. [http://www.unaids.org/en/dataanalysis/knowyourresponse/globalaidsprogressreporting/], UNAIDS.
168. UNAIDS Global AIDS Response Progress Reporting 2013: Construction of Core Indicators for Monitoring the 2011 UN Political Declaration on HIV/AIDS 2013, Geneva: UNAIDS, UNAIDS.
169. United Nations General Assembly General Assembly Special Session on HIV/AIDS. 25-27 June 2001. [http://www.un.org/ga/aids/coverage/], United Nations General Assembly.
170. United Nations General Assembly Political Declaration on HIV and AIDS: Intensifying our Efforts to Eliminate HIV and AIDS 2011, New York: United Nations, United Nations General Assembly.
171. UNAIDS Global AIDS Response Progress Reporting 2012: Guidelines: Construction of Core Indicators for Monitoring the 2011 UN Political Declaration on HIV/AIDS 2011, Geneva: UNAIDS, UNAIDS.
172. Taylor AL, Alfven T, Hougendobler D, Tanaka S, Buse K. Leveraging non-binding instruments for global health governance: reflections from the Global AIDS Reporting Mechanism for WHO Reform. Public Health 2013, 128:151-160.
173. World Health Organization Discussion paper. Development of an updated Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases Covering the Period 2013 to 2020. 26 July 2012. [http://www.who.int/nmh/events/2012/ncd_action_plan/en/index.html], World Health Organization.
174. Magnusson R, Patterson D. Role of law in global response to non-communicable diseases. Lancet 2011, 378:859-860. 10.1016/S0140-6736(11)60975-6, 21890035.
175. Attaran A, Pang T, Whitworth J, Oxman A, McKee M. Health by law: the missed opportunity to use laws for public health. Bull World Health Organ 2012, 379:283-285.
176. Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, Thamarangsi T, Lincoln P, Casswell S, . on behalf of the Lancet NCD Action Group Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet 2013, 381:670-679. 10.1016/S0140-6736(12)62089-3, 23410611, on behalf of the Lancet NCD Action Group.
177. Bryden A, Petticrew M, Mays N, Eastmure E, Knai C. Voluntary agreements between government and business - a scoping review of the literature with specific reference to the Public Health Responsibility Deal. Health Policy 2013, 110:186-197. 10.1016/j.healthpol.2013.02.009, 23506799.
178. Marks J. What's the big deal? The ethics of public-private partnerships related to health. [http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2268079].
179. Sharma L, Teret S, Brownell K. The food industry and self-regulation: standards to promote success and to avoid public health failures. Am J Public Health 2010, 100:240-246. 10.2105/AJPH.2009.160960, 2804645, 20019306.
180. Hashem K, Haigh C, Powell C. The irresponsibility deal?. [http://www.sustainweb.org/publications/?id=188].
181. Panjwani C, Caraher M. The public health responsibility deal: brokering a deal for public health, but on whose terms?. Health Policy 2014, 114:163-173. 10.1016/j.healthpol.2013.11.002, 24309298.
182. Framework Convention Alliance. [http://www.fctc.org].